Guanine deaminase Inhibitors (IC50, Ki)
Structure ▲ ▼ | Compound Name ▲ ▼ | Standard Type ▲ ▼ | Standard Values (in nM) ▲ ▼ |
Caffeine | Ki | 10200.0 [1] | |
Uric acid | Ki | 4340.0 [1] | |
Xanthine | Ki | 1960.0 [1] | |
5-Aminoimidazole-4-carboxamide | Ki | 4440.0 [1] | |
2,6-Diaminopurine | Ki | 1880.0 [1] | |
7-Methylxanthine | Ki | 5550.0 [1] | |
Azepinomycin | IC50 | 5000.0 [1] | |
2-Acetamido-6-hydroxypurine | Ki | 3440.0 [1] | |
3-Benzyl-6-(hydroxymethyl)-6,7-dihydro-4H-imidazo[4,5-e][1,4]diazepine-5,8-dione | Ki | 20100.0 [1] | |
6-(Hydroxymethyl)-1,4,6,7-tetrahydroimidazo[4,5-e][1,4]diazepine-5,8-dione | Ki | 53600.0 [1] |
References
This online tool may be cited as follows
MLA | "Quest Database™ Guanine deaminase Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 21 Nov. 2024, https://www.aatbio.com/data-sets/guanine-deaminase-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2024, November 21). Quest Database™ Guanine deaminase Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/guanine-deaminase-inhibitors-ic50-ki. | |
BibTeX | EndNote | RefMan |